Ionis Pharmaceuticals Inc (NASDAQ:IONS)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $873.8M
- Net income
- -$564.8M
- Net margin
- -64.6%
Heavily indebted for what it earns.
- Total debt
- $2.42B
- Cash
- $350.1M
- Debt / equity
- 5.50
Comfortably covers what is due within a year.
- Current assets
- $2.49B
- Current liabilities
- $316.0M
- Current ratio
- 7.88
Consumes cash and must keep raising it.
- Operating cash flow
- -$496.4M
- Free cash flow
- -$558.9M
- FCF margin
- -64.0%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 165.4M
- Share growth (1y)
- 3.9%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
IONS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 267.95 M | 246.09 M | 203.00 M | 156.72 M | 452.05 M | 131.61 M |
| Revenue Growth (YoY) | -40.73 % | 86.98 % | -10.41 % | 17.12 % | 100.69 % | 10.14 % |
| Cost of Revenue | 2.74 M | 2.98 M | 8.00 M | 2.34 M | 4.15 M | 1.50 M |
| Gross Profit | 265.21 M | 243.11 M | 195.00 M | 154.38 M | 447.90 M | 130.11 M |
| SG&A Expense | 150.40 M | 150.36 M | 130.00 M | 96.80 M | 90.60 M | 76.30 M |
| R&D Expense | 217.11 M | 210.17 M | 280.00 M | 217.75 M | 217.46 M | 200.76 M |
| Operating Expenses | 367.50 M | 360.53 M | 410.00 M | 314.56 M | 308.08 M | 276.97 M |
| Operating Income | -102.29 M | -117.42 M | -215.00 M | -160.18 M | 139.82 M | -146.86 M |
| Pretax Income | -113.38 M | -92.31 M | -228.00 M | -128.39 M | 123.53 M | -146.82 M |
| Tax Provision | -1.26 M | 218.00 K | 1.00 M | 213.00 K | -20.00 K | 116.00 K |
| Net Income | -114.65 M | -92.53 M | -229.00 M | -128.61 M | 123.55 M | -146.94 M |
| EPS (Basic) | -0.69 | -0.56 | -1.41 | -0.80 | 0.78 | -0.93 |
| EPS (Diluted) | -0.69 | -0.56 | -1.41 | -0.80 | 0.68 | -0.93 |
| Shares Outstanding | 165.42 M | 164.87 M | 162.00 M | 160.76 M | 159.14 M | 158.74 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.